TY - JOUR AU - Cazzola, M. AU - Calzetta, L. AU - Page, C. AU - Rogliani, P. AU - Matera, M. G. PY - 2018 DA - 2018// TI - Impact of erdosteine on chronic bronchitis and COPD: a meta-analysis JO - Pulm Pharmacol Ther VL - 48 UR - https://doi.org/10.1016/j.pupt.2017.11.009 DO - 10.1016/j.pupt.2017.11.009 ID - Cazzola2018 ER - TY - JOUR AU - Negro, R. W. PY - 2008 DA - 2008// TI - Erdosteine: antitussive and anti-inflammatory effects JO - Lung VL - 186 UR - https://doi.org/10.1007/s00408-007-9065-3 DO - 10.1007/s00408-007-9065-3 ID - Negro2008 ER - TY - JOUR AU - Moretti, M. PY - 2007 DA - 2007// TI - Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease JO - Expert Rev Respir Med VL - 1 UR - https://doi.org/10.1586/17476348.1.3.307 DO - 10.1586/17476348.1.3.307 ID - Moretti2007 ER - TY - JOUR AU - Moretti, M. PY - 2009 DA - 2009// TI - Erdosteine: its relevance in COPD treatment JO - Expert Opin Drug Metab Toxicol VL - 5 UR - https://doi.org/10.1517/17425250902814790 DO - 10.1517/17425250902814790 ID - Moretti2009 ER - TY - JOUR AU - Scaglione, F. AU - Petrini, O. PY - 2019 DA - 2019// TI - Mucoactive agents in the therapy of upper respiratory airways infections: fair to describe them just as mucoactive? JO - Clin Med Insights Ear Nose Throat VL - 12 UR - https://doi.org/10.1177/1179550618821930 DO - 10.1177/1179550618821930 ID - Scaglione2019 ER - TY - JOUR AU - Rogliani, P. AU - Matera, M. G. AU - Page, C. AU - Puxeddu, E. AU - Cazzola, M. AU - Calzetta, L. PY - 2019 DA - 2019// TI - Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine JO - Respir Res VL - 20 UR - https://doi.org/10.1186/s12931-019-1078-y DO - 10.1186/s12931-019-1078-y ID - Rogliani2019 ER - TY - JOUR AU - Edwards, I. R. AU - Aronson, J. K. PY - 2000 DA - 2000// TI - Adverse drug reactions: definitions, diagnosis, and management JO - Lancet VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)02799-9 DO - 10.1016/S0140-6736(00)02799-9 ID - Edwards2000 ER - TY - JOUR AU - Uzzaman, A. AU - Cho, S. H. PY - 2012 DA - 2012// TI - Chapter 28: classification of hypersensitivity reactions JO - Allergy Asthma Proc. VL - 33 UR - https://doi.org/10.2500/aap.2012.33.3561 DO - 10.2500/aap.2012.33.3561 ID - Uzzaman2012 ER - TY - JOUR AU - Lee, A. Y. PY - 2000 DA - 2000// TI - Fixed drug eruptions. Incidence, recognition, and avoidance JO - Am J Clin Dermatol. VL - 1 UR - https://doi.org/10.2165/00128071-200001050-00003 DO - 10.2165/00128071-200001050-00003 ID - Lee2000 ER - TY - JOUR AU - Namisato, M. AU - Ogawa, H. PY - 2000 DA - 2000// TI - Serious side effects of rifampin on the course of WHO/MDT: a case report JO - Int J Lepr Other Mycobact Dis VL - 68 ID - Namisato2000 ER - TY - JOUR AU - Luzzati, R. AU - Giacomazzi, D. AU - Franchi, F. AU - Barcobello, M. AU - Vento, S. PY - 2007 DA - 2007// TI - Life-threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis JO - South Med J VL - 100 UR - https://doi.org/10.1097/SMJ.0b013e3180f60a57 DO - 10.1097/SMJ.0b013e3180f60a57 ID - Luzzati2007 ER - TY - JOUR AU - Kim, D. H. AU - Choi, Y. H. AU - Kim, H. S. AU - Yu, J. E. AU - Koh, Y. I. PY - 2014 DA - 2014// TI - A case of serum sickness-like reaction and anaphylaxis—induced simultaneously by rifampin JO - Allergy Asthma Immunol Res VL - 6 UR - https://doi.org/10.4168/aair.2014.6.2.183 DO - 10.4168/aair.2014.6.2.183 ID - Kim2014 ER - TY - JOUR AU - Song, W. J. AU - Shim, E. J. AU - Kang, M. G. AU - Sohn, S. W. AU - Kang, H. R. PY - 2012 DA - 2012// TI - Severe drug hypersensitivity induced by erdosteine and doxofylline as confirmed by patch and lymphocyte transformation tests: a case report JO - J Investig Allergol Clin Immunol VL - 22 ID - Song2012 ER - TY - JOUR AU - Muraro, A. AU - Roberts, G. AU - Clark, A. AU - Eigenmann, P. A. AU - Halken, S. AU - Lack, G. PY - 2007 DA - 2007// TI - The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology JO - Allergy VL - 62 UR - https://doi.org/10.1111/j.1398-9995.2007.01421.x DO - 10.1111/j.1398-9995.2007.01421.x ID - Muraro2007 ER - TY - JOUR AU - Naranjo, C. A. AU - Busto, U. AU - Sellers, E. M. AU - Sandor, P. AU - Ruiz, I. AU - Roberts, E. A. PY - 1981 DA - 1981// TI - A method for estimating the probability of adverse drug reactions JO - Clin Pharmacol Ther VL - 30 UR - https://doi.org/10.1038/clpt.1981.154 DO - 10.1038/clpt.1981.154 ID - Naranjo1981 ER - TY - JOUR AU - Brahimi, N. AU - Routier, E. AU - Raison-Peyron, N. AU - Tronquoy, A. F. AU - Pouget-Jasson, C. AU - Amarger, S. PY - 2010 DA - 2010// TI - A three-year-analysis of fixed drug eruptions in hospital settings in France JO - Eur J Dermatol VL - 20 UR - https://doi.org/10.1684/ejd.2010.0980 DO - 10.1684/ejd.2010.0980 ID - Brahimi2010 ER - TY - JOUR AU - Garcia, D. AU - Cohen, P. R. PY - 2017 DA - 2017// TI - Dapsone-associated fixed drug eruption JO - Expert Rev Clin Pharmacol VL - 10 UR - https://doi.org/10.1080/17512433.2017.1322508 DO - 10.1080/17512433.2017.1322508 ID - Garcia2017 ER - TY - JOUR AU - Williams, K. W. AU - Sharma, H. P. PY - 2015 DA - 2015// TI - Anaphylaxis and urticaria JO - Immunol Allergy Clin North Am VL - 35 UR - https://doi.org/10.1016/j.iac.2014.09.010 DO - 10.1016/j.iac.2014.09.010 ID - Williams2015 ER - TY - JOUR AU - Sacchelli, L. AU - Banzola, N. AU - Traniello Gradassi, A. AU - Patrizi, A. AU - D'Antuono, A. PY - 2019 DA - 2019// TI - Can a single drug administration elicit two different immunological pathways at the same time? Fixed drug eruption after anaphylaxis JO - G Ital Dermatol Venereol VL - 154 UR - https://doi.org/10.23736/S0392-0488.17.05699-1 DO - 10.23736/S0392-0488.17.05699-1 ID - Sacchelli2019 ER - TY - JOUR AU - Honda, T. AU - Kabashima, K. AU - Fujii, Y. AU - Katoh, M. AU - Miyachi, Y. PY - 2014 DA - 2014// TI - Autoimmune progesterone dermatitis that changed its clinical manifestation from anaphylaxis to fixed drug eruption-like erythema JO - J Dermatol VL - 41 UR - https://doi.org/10.1111/1346-8138.12473 DO - 10.1111/1346-8138.12473 ID - Honda2014 ER -